Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

161
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
161

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Multiparametric Characterization of Tough Clots Following Stroke Thrombectomy.

Clinical neuroradiology·2026
Same author

Author response to Sinha, "Comment on "Intracranial hemorrhage after ischemic stroke in patients on direct oral anticoagulants: Results from a prospective observational study"".

Neurological research and practice·2026
Same author

Hierarchical composite outcomes in acute ischaemic stroke with large infarct: a win ratio analysis of the TENSION trial.

European stroke journal·2026
Same author

Impact of Anesthesia on Thrombectomy Outcomes in Large Stroke: a TENSION Subanalysis.

Clinical neuroradiology·2026
Same author

Large Core Stroke Thrombectomy Is Safe and Effective Regardless of Prior Antithrombotic or Thrombolytic Treatment: A Secondary Analysis of the Randomized TENSION Trial.

Journal of the American Heart Association·2026
Same author

Safety of Endovascular Thrombectomy in Isolated Cervical Internal Carotid Artery Occlusion While on Oral Anticoagulation.

Journal of stroke·2026

相关实验视频

Updated: Jun 3, 2025

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
09:21

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Published on: January 18, 2018

12.0K

[急性缺血性中风治疗] [急性缺血性中风治疗]

Muadh Hussain1, Jan Purrucker2, Peter Ringleb2

  • 1Neurologische Klinik, Universitätsklinikum Heidelberg, Im Neuenheimer Feld 400, 69120, Heidelberg, Deutschland. muadh.hussain@med.uni-heidelberg.de.

Medizinische Klinik, Intensivmedizin und Notfallmedizin
|January 9, 2025
PubMed
概括

急性缺血性中风的治疗依赖于静脉输血栓溶解 (IVT) 和内血管治疗 (EVT). 甲 (TNK) 显示为IVT中高甲 (rtPA) 的非劣质替代品,有望改善再通道化时间.

关键词:
在Alteplase的位置上栓塞性中风是因为太尼克特代替了太尼克特.血栓溶解药物治疗的方法组织等离子素激活剂

更多相关视频

Setting Up a Stroke Team Algorithm and Conducting Simulation-based Training in the Emergency Department - A Practical Guide
09:52

Setting Up a Stroke Team Algorithm and Conducting Simulation-based Training in the Emergency Department - A Practical Guide

Published on: January 15, 2017

17.1K
Prehospital Thrombolysis: A Manual from Berlin
05:52

Prehospital Thrombolysis: A Manual from Berlin

Published on: November 26, 2013

21.8K

相关实验视频

Last Updated: Jun 3, 2025

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
09:21

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Published on: January 18, 2018

12.0K
Setting Up a Stroke Team Algorithm and Conducting Simulation-based Training in the Emergency Department - A Practical Guide
09:52

Setting Up a Stroke Team Algorithm and Conducting Simulation-based Training in the Emergency Department - A Practical Guide

Published on: January 15, 2017

17.1K
Prehospital Thrombolysis: A Manual from Berlin
05:52

Prehospital Thrombolysis: A Manual from Berlin

Published on: November 26, 2013

21.8K

科学领域:

  • 神经学 神经学
  • 血管医学 血管医学
  • 紧急医疗 紧急医疗

背景情况:

  • 静脉内血栓溶解 (IVT) 和内血管治疗 (EVT) 是急性缺血性中风的主要治疗方法.
  • 化酶 (rtPA) 已成为IVT的标准,而化酶 (TNK) 已成为可比的替代品.
  • 在过去的十年中,EVT已成为一种非常有效的治疗方法,特别是在大型血管封闭的情况下.

研究的目的:

  • 为了比较IVT和EVT在急性缺血性中风管理中的有效性和应用.
  • 为了突出中风重治疗的时间敏感性.
  • 讨论患者选择标准和对IVT和EVT的资源影响.

主要方法:

  • 对IVT和EVT对急性缺血性中风的当前文献的综述.
  • 对rtPA和TNK的药理性质和临床结果的分析.
  • 检查IVT和EVT的既定和延长的时间窗口.
  • 讨论在EVT中选择患者的先进成像技术.

主要成果:

  • 甲酸 (TNK) 与高甲酸 (rtPA) 不逊色,可以提供更早的再通道,特别是在大血管封闭的情况下.
  • IVT的最佳时间窗口为4.5小时,可通过先进的成像扩展到9小时.
  • EVT的时间窗口长达24小时,在某些特定情况下可能在此之外使用.
  • EVT需要专门的中心和人员,而IVT更容易获得.

结论:

  • IVT和EVT都对急性缺血性中风至关重要,TNK比rtPA具有潜在的优势.
  • 使用先进成像技术进行最佳的患者选择对于EVT至关重要,特别是在大型血管封闭的情况下.
  • 在4.5小时的窗口内将IVT和EVT结合起来,为符合条件的患者提供了最好的结果.
  • 标准操作程序对于及时管理这些时间关键的中风疗法至关重要.